Search results
Intercept Pharmaceutical Stock Shows Market Leadership; Earns 92 RS Rating
Investor's Business Daily· 2 years agoIntercept Pharmaceutical stock had its Relative Strength (RS) Rating upgraded from 89 to 92 Tuesday....
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
Investor's Business Daily· 2 years agoIntercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis,...
Intercept Pharmaceuticals (ICPT) Surges on Acquisition Deal
Zacks via Yahoo Finance· 9 months agoShares of Intercept Pharmaceuticals, Inc. ICPT soared 79.2% after Italy-based pharmaceutical company...
Intercept Pharmaceutical Stock Sees RS Rating Rise To 91
Investor's Business Daily· 2 years agoWhen looking for the best stocks to buy and watch, focus on those with rising relative price...
Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug
Investor's Business Daily· 12 months agoIntercept Pharmaceuticals said Friday it will restructure itself after the Food and Drug...
Nike's Down, but These 2 Nasdaq Stocks Fell Even Further Friday
Motley Fool· 2 years agoFutures on the Nasdaq Composite (NASDAQINDEX: ^IXIC) were all over the map in premarket trading...
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals said Friday its experimental liver disease treatment will face a Food and...
Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates
Zacks via Yahoo Finance· 1 year agoThe biotech sector has been in focus in the past week with key pipeline and regulatory updates....
Intercept (ICPT) Stock Down on FDA Committee Update on NDA
Zacks via Yahoo Finance· 1 year agoIntercept Pharmaceuticals, Inc. ICPT announced that the Gastrointestinal Drugs Advisory Committee...
Why CymaBay, With 159% Growth This Year, Just Surged For A Second Day Running
Investor's Business Daily· 9 months agoShares of CBAY stock surged for a second day Friday as analysts compared CymaBay Therapeutics'...